Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Meiji Seika's new orally active gpIIb/IIIa antagonist

March 20, 1997

Agent for atopic dermatitis reported by Terumo

March 20, 1997

Highly potent and selective ETA antagonist from Tanabe Seiyaku

March 20, 1997

Mitsui Toatsu reveals orally active antiplatelet agent

March 20, 1997

Hirosaki University researchers present novel class Ib antiarrhythmic

March 20, 1997

Grelan characterizes candidate for diabetic complications

March 20, 1997

Eisai discovers novel selective PDE I inhibitor

March 19, 1997

Antihyperalgesic effects of bradykinin B2 antagonist from Fujisawa

March 19, 1997

JT characterizes novel COX-2 inhibitor

March 19, 1997

Novel Na+/H+-exchange inhibitor from Fujisawa with cardioprotective effects

March 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...